General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Cash Flows

v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities        
Net loss $ (3,272,963) $ (1,560,072) $ (8,154,113) $ (6,326,413)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 43,236 2,079 10,182 4,817
Accretion of debt issuance costs 1,205,255 2,055,627 480,574
Fair value adjustments on convertible notes payable (1,186,992) 1,866,922 (724,928)
Stock-based compensation expense 327,868 132,732 248,592 43,012
Fair value of warrants issued     4,080,339
Gain on extinguishment of debt (212,258) (212,258) (239,200)
Changes in operating assets and liabilities:        
Accounts and other receivables (79,743) (6,287) (8,959)
Inventory (4,561) (5,657) (5,540)
Prepaid expenses and other assets 251,292 (28,304) (492,753) (34,990)
Accounts payable (170,638) 354,560 114,635 39,020
Accrued expenses (26,231) (42,730) 66,335 107,744
Accrued interest 337,566 440,485 521,047
Unearned revenue 42,750      
Net cash used in operating activities (2,888,990) (1,010,108) (4,070,845) (2,048,978)
Cash flows from investing activities        
Purchase of property and equipment (36,175) (219,987)
Net cash used in investing activities (36,175) (219,987)
Cash flows from financing activities        
Proceeds from loan payable     555,148 212,258
Payment on loans payable (209,412) (269,983)
Payment of debt (100,000)    
Issuance of loan payable   65,031    
Proceeds from issuance of convertible notes payable 475,000 724,000 3,295,000
Repayment of convertible loan payable     (425,000)
Proceeds from issuance of common stock from the initial public offering, net of underwriting discounts, commissions and offering expenses of approximately $1.8 million     6,027,414
Exercise of warrants     7,713,310
Exercise of stock options     74,900
Return of capital from stock split     (185)
Payment of deferred offering costs (520,506)    
Payment of debt issuance costs (55,651) (55,651) (180,750)
Net cash provided by financing activities (209,412) (136,126) 14,343,953 3,326,508
Net increase in cash and cash equivalents (3,134,577) (1,146,234) 10,053,121 1,277,530
Cash and cash equivalents at beginning of year 11,413,759 1,360,638 1,360,638 83,108
Cash and cash equivalents at end of year 8,279,182 214,404 11,413,759 1,360,638
Supplemental disclosures of cash flow information:        
Income taxes paid in cash 16,406 2,159 2,459 1,950
Interest paid 3,015 30,637
Conversion of convertible preferred stock into common stock     4,044,318
Conversion of convertible notes payable into common stock     16,065,332
Noncash financing activities:        
Fair value of warrants issued to placement agents 217,973 352,250 74,556
Beneficial conversion feature for bridge notes $ 213,942 $ 462,344 $ 739,602